Skip to content

Exercise and Parkinson's: Comparing Interventions and Exploring Neural Mechanisms

Exercise and Parkinson's: Comparing Interventions and Exploring Neural Mechanisms

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01768832
Enrollment
119
Registered
2013-01-15
Start date
2013-02-28
Completion date
2018-07-31
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Parkinson disease, walking, fMRI, exercise, dance, treadmill

Brief summary

Parkinson disease (PD) is characterized by substantial disability and reduced quality of life, both of which can be attributed in large part to difficulties with walking. Evidence suggests that exercise may be an important addition to traditional treatments, particularly with respect to addressing walking problems. In particular, dance and treadmill training have been individually shown to improve walking performance and quality of life. At present it is not clear whether dance or treadmill training have similar effects or if one is superior to the other. Furthermore, our understanding of the means by which these exercise interventions convey benefits is extremely limited. This study aims to address these knowledge gaps by directly comparing dance, treadmill training and stretching (control group). The primary area of interest is the effects on gait, with secondary measures of disease severity, balance, and quality of life. The investigators will determine not only the effects of the interventions on walking performance, but will also investigate the effects of the interventions on connections between different parts of the brain and on brain function during imagined walking tasks using functional magnetic resonance imaging (fMRI). Participants will be randomly assigned to dance, treadmill training, or a stretching/flexibility control group. Participants will be assessed over a period of 6 months at 3 different time points. The investigators hypothesize that both dance and treadmill training will lead to improvements in forward walking, but that dance will result in greater improvements in backward walking compared to treadmill training. Furthermore, the investigators hypothesize that the tango and treadmill interventions will have different effects of brain function and brain connections. The investigators expect dance to enhance the activity and connections of particular brain regions and treadmill training to enhance activity and connections of different brain regions. The investigators do not expect changes in brain activity or connections in the control group.

Interventions

BEHAVIORALTreadmill
BEHAVIORALTango
BEHAVIORALStretching

Sponsors

Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. diagnosis of Parkinson disease 2. at least grade 3/5 strength and normal joint ranges of motion in both legs, 3. vision corrected to 20/40 or better, 4. able to walk independently for 10 feet with or without an assistive device, 5) normal gross somatosensory function in the feet (2-point discrimination, vibration, joint kinesthesia, and light touch), 6\) no history of vestibular disease, 7) no evidence of dementia

Exclusion criteria

1. medical condition for which exercise is contraindicated, 2. evidence of abnormality other than PD-related changes on brain imaging, 3. history or evidence of neurological deficit other than PD that could interfere, such as previous stroke or muscle disease, 4. history or evidence of orthopedic or muscular problem, 5. failed to pass magnetic resonance imaging screening procedure

Design outcomes

Primary

MeasureTime frameDescription
Walking Velocity at Baseline and 3 Months0 and 3 monthsWalking velocity during forward and backward walking as determined by a computerized mat.

Secondary

MeasureTime frameDescription
Mini Balance Evaluation Systems Test (Mini-BESTest) at Baseline and 3 Months0 and 3 monthsThe Mini Balance Evaluation Systems Test (Mini-BESTest) is a clinical assessment of balance ability. Score range from 0 to 28 with higher scores indicating better balance.
PDQ-39 Scores at Baseline and 3 Months0 and 3 monthsThe Parkinson Disease Quality of Life Questionnaire is a 39-item tool rating quality of life with higher scores indicating better quality of life. Scores range from 0 to 195.
Movement Disorder Society Unified Parkinson Disease Rating Scale Subscale III at Baseline to 3 Months0 and 3 monthsThe Movement Disorder Society Unified Parkinson Disease Rating Scale - Subscale III is a standardized rating of motor symptom severity in Parkinson disease. Scores range from 0 to 132 with higher scores being worse, i.e. higher scores indicate more severe disease.
Blood Oxygen Level Dependent Signal at Baseline to 3 Months0 and 3 monthsMeasure of the ratio of oxygenated to deoxygenated blood in areas of the brain at a specific time. Used as an indirect assessment of brain activity and connections. Higher values indicate more brain activity in the brain areas of interest.
Movement Disorder Society Unified Parkinson Disease Rating Scale Subscale III at 3 Months and 6 Months3 and 6 monthsThe Movement Disorder Society Unified Parkinson Disease Rating Scale - Subscale III is a standardized rating of motor symptom severity in Parkinson disease. Scores range from 0 to 132 with higher scores being worse, i.e. higher scores indicate more severe disease.
PDQ-39 Scores at 3 Months and 6 Months3 and 6 monthsThe Parkinson Disease Quality of Life Questionnaire is a 39-item tool rating quality of life with higher scores indicating better quality of life. Scores range from 0 to 195.
Walking Velocity at 3 Months and 6 Months3 and 6 monthsWalking velocity during forward and backward walking as determined by a computerized mat.
Mini Balance Evaluation Systems Test (Mini-BESTest) at 3 and 6 Months3 and 6 monthsThe Mini Balance Evaluation Systems Test (Mini-BESTest) is a clinical assessment of balance ability. Score range from 0 to 28 with higher scores indicating better balance.

Countries

United States

Participant flow

Participants by arm

ArmCount
Treadmill
Individuals assigned to the Treadmill group will complete two one hour treadmill training sessions per week for 12 weeks. Treadmill
31
Tango
Individuals assigned to the Tango group will complete two one hour dance classes twice per week for 12 weeks. Tango
39
Stretching
Individuals assigned to Stretching will complete two one hour stretching classes per week for 12 weeks. Stretching
26
Total96

Baseline characteristics

CharacteristicTreadmillTangoStretchingTotal
Age, Continuous68.52 years
STANDARD_DEVIATION 9.54
66.73 years
STANDARD_DEVIATION 9.52
66.18 years
STANDARD_DEVIATION 7.3
67.16 years
STANDARD_DEVIATION 8.94
Disease Duration5.59 years
STANDARD_DEVIATION 3.81
6.10 years
STANDARD_DEVIATION 4.82
4.40 years
STANDARD_DEVIATION 5.04
5.47 years
STANDARD_DEVIATION 4.59
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants0 Participants0 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
30 Participants39 Participants26 Participants95 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants0 Participants0 Participants1 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants2 Participants2 Participants
Race (NIH/OMB)
Black or African American
1 Participants0 Participants1 Participants2 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
29 Participants39 Participants23 Participants91 Participants
Sex: Female, Male
Female
14 Participants14 Participants12 Participants40 Participants
Sex: Female, Male
Male
17 Participants25 Participants14 Participants56 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 310 / 390 / 26
other
Total, other adverse events
0 / 310 / 390 / 26
serious
Total, serious adverse events
0 / 310 / 390 / 26

Outcome results

Primary

Walking Velocity at Baseline and 3 Months

Walking velocity during forward and backward walking as determined by a computerized mat.

Time frame: 0 and 3 months

ArmMeasureGroupValue (MEAN)Dispersion
TreadmillWalking Velocity at Baseline and 3 MonthsBaseline Forward Walking Velocity103.28 cm/secStandard Deviation 4.67
TreadmillWalking Velocity at Baseline and 3 MonthsForward Walking Velocity at 3 months109.57 cm/secStandard Deviation 4.65
TreadmillWalking Velocity at Baseline and 3 MonthsBaseline Backward Walking Velocity63.45 cm/secStandard Deviation 4.22
TreadmillWalking Velocity at Baseline and 3 MonthsBackward Walking Velocity at 3 months64.89 cm/secStandard Deviation 3.72
TangoWalking Velocity at Baseline and 3 MonthsBackward Walking Velocity at 3 months71.87 cm/secStandard Deviation 4.83
TangoWalking Velocity at Baseline and 3 MonthsBaseline Forward Walking Velocity104.53 cm/secStandard Deviation 3.92
TangoWalking Velocity at Baseline and 3 MonthsBaseline Backward Walking Velocity60.80 cm/secStandard Deviation 3.7
TangoWalking Velocity at Baseline and 3 MonthsForward Walking Velocity at 3 months103.36 cm/secStandard Deviation 4.21
StretchingWalking Velocity at Baseline and 3 MonthsBackward Walking Velocity at 3 months75.17 cm/secStandard Deviation 6.69
StretchingWalking Velocity at Baseline and 3 MonthsForward Walking Velocity at 3 months110.52 cm/secStandard Deviation 5.02
StretchingWalking Velocity at Baseline and 3 MonthsBaseline Backward Walking Velocity65.17 cm/secStandard Deviation 4.6
StretchingWalking Velocity at Baseline and 3 MonthsBaseline Forward Walking Velocity111.21 cm/secStandard Deviation 3.81
Secondary

Blood Oxygen Level Dependent Signal at Baseline to 3 Months

Measure of the ratio of oxygenated to deoxygenated blood in areas of the brain at a specific time. Used as an indirect assessment of brain activity and connections. Higher values indicate more brain activity in the brain areas of interest.

Time frame: 0 and 3 months

Population: Due to issues with data quality related to head movement while in the MRI scanner, we had a limited numbers of participants in each group with usable MRI data.

ArmMeasureGroupValue (MEAN)Dispersion
TreadmillBlood Oxygen Level Dependent Signal at Baseline to 3 MonthsBold Signal at Baseline in Primary Motor Cortex.110 ratioStandard Deviation 0.165
TreadmillBlood Oxygen Level Dependent Signal at Baseline to 3 MonthsBold Signal at 3 months in Primary Motor Cortex.126 ratioStandard Deviation 0.246
TangoBlood Oxygen Level Dependent Signal at Baseline to 3 MonthsBold Signal at Baseline in Primary Motor Cortex.043 ratioStandard Deviation 0.255
TangoBlood Oxygen Level Dependent Signal at Baseline to 3 MonthsBold Signal at 3 months in Primary Motor Cortex.111 ratioStandard Deviation 0.242
StretchingBlood Oxygen Level Dependent Signal at Baseline to 3 MonthsBold Signal at Baseline in Primary Motor Cortex.095 ratioStandard Deviation 0.307
StretchingBlood Oxygen Level Dependent Signal at Baseline to 3 MonthsBold Signal at 3 months in Primary Motor Cortex.117 ratioStandard Deviation 0.159
Secondary

Mini Balance Evaluation Systems Test (Mini-BESTest) at 3 and 6 Months

The Mini Balance Evaluation Systems Test (Mini-BESTest) is a clinical assessment of balance ability. Score range from 0 to 28 with higher scores indicating better balance.

Time frame: 3 and 6 months

ArmMeasureGroupValue (MEDIAN)
TreadmillMini Balance Evaluation Systems Test (Mini-BESTest) at 3 and 6 MonthsMiniBESTest at 3 months20 score on a scale
TreadmillMini Balance Evaluation Systems Test (Mini-BESTest) at 3 and 6 MonthsMiniBESTest at 6 months20 score on a scale
TangoMini Balance Evaluation Systems Test (Mini-BESTest) at 3 and 6 MonthsMiniBESTest at 3 months20 score on a scale
TangoMini Balance Evaluation Systems Test (Mini-BESTest) at 3 and 6 MonthsMiniBESTest at 6 months19 score on a scale
StretchingMini Balance Evaluation Systems Test (Mini-BESTest) at 3 and 6 MonthsMiniBESTest at 3 months21 score on a scale
StretchingMini Balance Evaluation Systems Test (Mini-BESTest) at 3 and 6 MonthsMiniBESTest at 6 months20 score on a scale
Secondary

Mini Balance Evaluation Systems Test (Mini-BESTest) at Baseline and 3 Months

The Mini Balance Evaluation Systems Test (Mini-BESTest) is a clinical assessment of balance ability. Score range from 0 to 28 with higher scores indicating better balance.

Time frame: 0 and 3 months

ArmMeasureGroupValue (MEDIAN)
TreadmillMini Balance Evaluation Systems Test (Mini-BESTest) at Baseline and 3 MonthsMiniBEST at baseline19 score on a scale
TreadmillMini Balance Evaluation Systems Test (Mini-BESTest) at Baseline and 3 MonthsMiniBESTest at 3 months19 score on a scale
TangoMini Balance Evaluation Systems Test (Mini-BESTest) at Baseline and 3 MonthsMiniBEST at baseline19 score on a scale
TangoMini Balance Evaluation Systems Test (Mini-BESTest) at Baseline and 3 MonthsMiniBESTest at 3 months19 score on a scale
StretchingMini Balance Evaluation Systems Test (Mini-BESTest) at Baseline and 3 MonthsMiniBEST at baseline20 score on a scale
StretchingMini Balance Evaluation Systems Test (Mini-BESTest) at Baseline and 3 MonthsMiniBESTest at 3 months21 score on a scale
Secondary

Movement Disorder Society Unified Parkinson Disease Rating Scale Subscale III at 3 Months and 6 Months

The Movement Disorder Society Unified Parkinson Disease Rating Scale - Subscale III is a standardized rating of motor symptom severity in Parkinson disease. Scores range from 0 to 132 with higher scores being worse, i.e. higher scores indicate more severe disease.

Time frame: 3 and 6 months

Population: Analysis included only participants who completed the study visit at the six month time point.

ArmMeasureGroupValue (MEDIAN)
TreadmillMovement Disorder Society Unified Parkinson Disease Rating Scale Subscale III at 3 Months and 6 MonthsMDS-UPDRS-III at 3 months32 score on a scale
TreadmillMovement Disorder Society Unified Parkinson Disease Rating Scale Subscale III at 3 Months and 6 MonthsMDS-UPDRS-III at 6 months32 score on a scale
TangoMovement Disorder Society Unified Parkinson Disease Rating Scale Subscale III at 3 Months and 6 MonthsMDS-UPDRS-III at 3 months32 score on a scale
TangoMovement Disorder Society Unified Parkinson Disease Rating Scale Subscale III at 3 Months and 6 MonthsMDS-UPDRS-III at 6 months35 score on a scale
StretchingMovement Disorder Society Unified Parkinson Disease Rating Scale Subscale III at 3 Months and 6 MonthsMDS-UPDRS-III at 3 months33 score on a scale
StretchingMovement Disorder Society Unified Parkinson Disease Rating Scale Subscale III at 3 Months and 6 MonthsMDS-UPDRS-III at 6 months38 score on a scale
Secondary

Movement Disorder Society Unified Parkinson Disease Rating Scale Subscale III at Baseline to 3 Months

The Movement Disorder Society Unified Parkinson Disease Rating Scale - Subscale III is a standardized rating of motor symptom severity in Parkinson disease. Scores range from 0 to 132 with higher scores being worse, i.e. higher scores indicate more severe disease.

Time frame: 0 and 3 months

ArmMeasureGroupValue (MEDIAN)
TreadmillMovement Disorder Society Unified Parkinson Disease Rating Scale Subscale III at Baseline to 3 MonthsMDS-UPDRS-III at baseline37 score on a scale
TreadmillMovement Disorder Society Unified Parkinson Disease Rating Scale Subscale III at Baseline to 3 MonthsMDS-UPDRS-III at 3 months33 score on a scale
TangoMovement Disorder Society Unified Parkinson Disease Rating Scale Subscale III at Baseline to 3 MonthsMDS-UPDRS-III at baseline37 score on a scale
TangoMovement Disorder Society Unified Parkinson Disease Rating Scale Subscale III at Baseline to 3 MonthsMDS-UPDRS-III at 3 months33 score on a scale
StretchingMovement Disorder Society Unified Parkinson Disease Rating Scale Subscale III at Baseline to 3 MonthsMDS-UPDRS-III at baseline38 score on a scale
StretchingMovement Disorder Society Unified Parkinson Disease Rating Scale Subscale III at Baseline to 3 MonthsMDS-UPDRS-III at 3 months33 score on a scale
Secondary

PDQ-39 Scores at 3 Months and 6 Months

The Parkinson Disease Quality of Life Questionnaire is a 39-item tool rating quality of life with higher scores indicating better quality of life. Scores range from 0 to 195.

Time frame: 3 and 6 months

ArmMeasureGroupValue (MEAN)Dispersion
TreadmillPDQ-39 Scores at 3 Months and 6 MonthsPDQ-39 at 3 months17.86 score on a scaleStandard Deviation 2.41
TreadmillPDQ-39 Scores at 3 Months and 6 MonthsPDQ-39 at 6 months12.66 score on a scaleStandard Deviation 2.41
TangoPDQ-39 Scores at 3 Months and 6 MonthsPDQ-39 at 3 months18.80 score on a scaleStandard Deviation 1.85
TangoPDQ-39 Scores at 3 Months and 6 MonthsPDQ-39 at 6 months19.20 score on a scaleStandard Deviation 1.75
StretchingPDQ-39 Scores at 3 Months and 6 MonthsPDQ-39 at 3 months16.39 score on a scaleStandard Deviation 2.35
StretchingPDQ-39 Scores at 3 Months and 6 MonthsPDQ-39 at 6 months9.33 score on a scaleStandard Deviation 1.4
Secondary

PDQ-39 Scores at Baseline and 3 Months

The Parkinson Disease Quality of Life Questionnaire is a 39-item tool rating quality of life with higher scores indicating better quality of life. Scores range from 0 to 195.

Time frame: 0 and 3 months

ArmMeasureGroupValue (MEAN)Dispersion
TreadmillPDQ-39 Scores at Baseline and 3 MonthsPDQ-39 at baseline19.22 score on a scaleStandard Deviation 2.71
TreadmillPDQ-39 Scores at Baseline and 3 MonthsPDQ-39 at 3 months17.86 score on a scaleStandard Deviation 2.41
TangoPDQ-39 Scores at Baseline and 3 MonthsPDQ-39 at baseline18.33 score on a scaleStandard Deviation 1.89
TangoPDQ-39 Scores at Baseline and 3 MonthsPDQ-39 at 3 months18.80 score on a scaleStandard Deviation 1.85
StretchingPDQ-39 Scores at Baseline and 3 MonthsPDQ-39 at baseline16.30 score on a scaleStandard Deviation 1.86
StretchingPDQ-39 Scores at Baseline and 3 MonthsPDQ-39 at 3 months16.39 score on a scaleStandard Deviation 2.35
Secondary

Walking Velocity at 3 Months and 6 Months

Walking velocity during forward and backward walking as determined by a computerized mat.

Time frame: 3 and 6 months

Population: Analysis included only those participants who completed the 6 month visit.

ArmMeasureGroupValue (MEDIAN)
TreadmillWalking Velocity at 3 Months and 6 MonthsForward Walking Velocity at 3 months116.7 cm/sec
TreadmillWalking Velocity at 3 Months and 6 MonthsForward Walking Velocity at 6 months113.9 cm/sec
TreadmillWalking Velocity at 3 Months and 6 MonthsBackward Walking Velocity at 3 months78.8 cm/sec
TreadmillWalking Velocity at 3 Months and 6 MonthsBackward Walking Velocity at 6 months74.2 cm/sec
TangoWalking Velocity at 3 Months and 6 MonthsBackward Walking Velocity at 6 months70.3 cm/sec
TangoWalking Velocity at 3 Months and 6 MonthsForward Walking Velocity at 3 months109.7 cm/sec
TangoWalking Velocity at 3 Months and 6 MonthsBackward Walking Velocity at 3 months67.8 cm/sec
TangoWalking Velocity at 3 Months and 6 MonthsForward Walking Velocity at 6 months108.4 cm/sec
StretchingWalking Velocity at 3 Months and 6 MonthsBackward Walking Velocity at 6 months68.2 cm/sec
StretchingWalking Velocity at 3 Months and 6 MonthsForward Walking Velocity at 6 months117 cm/sec
StretchingWalking Velocity at 3 Months and 6 MonthsBackward Walking Velocity at 3 months73.4 cm/sec
StretchingWalking Velocity at 3 Months and 6 MonthsForward Walking Velocity at 3 months111.6 cm/sec

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026